Trademark: 79325247
Word
ALBUMOD
Status
Registered
Status Code
700
Status Date
Tuesday, April 11, 2023
Serial Number
79325247
Registration Number
7021137
Registration Date
Tuesday, April 11, 2023
Mark Type
4000
Filing Date
Wednesday, July 28, 2021
Published for Opposition
Tuesday, January 24, 2023

Trademark Owner History
Affibody AB - Original Registrant

Classifications
5 Medical and veterinary preparations and articles, namely, pharmaceutical preparations for half-life extension and enhancement of efficacy of protein therapeutics; pharmaceutical preparations and substances, namely, a pharmaceutical agent consisting of compounds comprised of albumin-binding domains and albumin that facilitate delivery of a wide range of pharmaceuticals; biochemical preparations for medical use for the treatment of systemic and local diseases; biochemical pharmaceutical preparations for medical use for half-life extension and enhancement of efficacy of protein therapeutics; antibodies and antibodies-based pharmaceutical preparations for medical purposes for half-life extension and enhancement of efficacy of protein therapeutics; diagnostic preparations and materials; reagents for medical use; biochemical biomarker reagents for medical use; diagnostic biomarker reagents for medical purposes; sanitary preparations for medical purposes
1 Chemical substance preparations, chemical materials preparations and chemical preparations all for scientific purposes, and chemical elements, namely, chemical elements used in pharmaceuticals for scientific purposes; chemical substances and materials used to enhance the efficacy of biopharmaceuticals for industrial, scientific and laboratory purposes; biochemical substances preparations for scientific purposes; chemical substances for use in the production of drugs, pharmaceuticals and antibodies; Biochemical reagents for scientific, laboratory, analysis, research, medical research, testing, inspection, detecting and verification use, other than for medical or veterinary purposes; reagents for research use in the development of antibodies, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; antibodies and antibodies-based chemical reagents for non-medical and non-veterinary use
44 medical services; providing medical information; physical examination services; medical diagnostic testing, monitoring and reporting services; optical medical imaging services for medical diagnostic use; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposes
10 Medical and veterinary apparatus and instruments, namely, medical apparatus and instruments for use in surgery; Diagnostic, examination, and monitoring equipment for medical use, namely, medical apparatus and instruments for diagnostic radiopharmaceutical use; Medical and veterinary apparatus and instruments, namely, Hematology analyzers for medical diagnostic uses; Medical and veterinary apparatus and instruments, namely, Medical diagnostic instruments for the analysis of body fluids; Medical and veterinary apparatus and instruments, namely, X-ray diagnostic apparatus; Medical and veterinary apparatus and instruments, namely, Medical diagnostic apparatus for detecting cancer or and inflammation; Medical and veterinary apparatus and instruments, namely, Ultrasonic medical diagnostic apparatus; Medical and veterinary apparatus and instruments, namely, Medical diagnostic apparatus for testing DNA and RNA samples; Separation instruments for medical use, namely, blood component separation apparatus for medical purposes; Medical devices, namely, surgical devices that facilitate the identification, separation or ablation of biologic tissues; Gas chromatographic instruments for medical use; Electromagnetic diagnostic imaging apparatus for medical use; Medication fluid injectors for medical use
42 Scientific and technological services and research, development and design in the fields of half-life extension, pharmacokinetics and pharmacodynamics; medical and pharmacological research services for medical purposes in the field of half-life extension, pharmacokinetics and pharmacodynamics; medical, pharmaceutical and biotechnological laboratory research services for medical purposes in the field of half-life extension, pharmacokinetics and pharmacodynamics; scientific investigations for medical purposes; Scientific research in the nature of conducting clinical trials for others; providing medical and scientific research information about the results of clinical trials for pharmaceutical products; biochemical analysis and research for medical purposes in the field of half-life extension, pharmacokinetics and pharmacodynamics; drug discovery services; pharmaceutical products development and evaluation

Trademark Events
Aug 14, 2023
Final Decision Transaction Processed By Ib
Jul 26, 2023
Final Disposition Notice Sent To Ib
Jul 26, 2023
Final Disposition Processed
Jul 11, 2023
Final Disposition Notice Created, To Be Sent To Ib
Apr 11, 2023
Notice Of Registration Confirmation Emailed
Apr 11, 2023
Registered-Principal Register
Jan 24, 2023
Notification Processed By Ib
Jan 24, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 24, 2023
Published For Opposition
Jan 4, 2023
Notification Of Possible Opposition Sent To Ib
Jan 4, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 4, 2023
Notification Of Notice Of Publication E-Mailed
Dec 16, 2022
Approved For Pub - Principal Register
Dec 16, 2022
Examiner's Amendment Entered
Dec 16, 2022
Notification Of Examiners Amendment E-Mailed
Dec 16, 2022
Examiners Amendment E-Mailed
Dec 16, 2022
Examiners Amendment -Written
Nov 29, 2022
Teas/Email Correspondence Entered
Nov 29, 2022
Correspondence Received In Law Office
Nov 29, 2022
Teas Response To Office Action Received
Jun 28, 2022
Refusal Processed By Ib
Jun 8, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Jun 8, 2022
Refusal Processed By Mpu
May 5, 2022
Non-Final Action (Ib Refusal) Prepared For Review
May 4, 2022
Non-Final Action Written
Apr 25, 2022
Assigned To Examiner
Nov 16, 2021
Application Filing Receipt Mailed
Nov 12, 2021
New Application Office Supplied Data Entered
Nov 11, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24